Nidan Laboratories and Healthcare (NSE:NIDAN) Marketable Securities: ₹0.0 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NIDAN Nidan Laboratories and Healthcare Ltd NSE:NIDAN
67 GF Score
Price ₹13.50
View Full Analysis

What is Nidan Laboratories and Healthcare Marketable Securities?

Nidan Laboratories and Healthcare NSE:NIDAN +2.66% 67 Marketable Securities is ₹0.0 Mil as of Mar. 2025. GuruFocus rates NSE:NIDAN with a GF Score™ of 67/100.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Nidan Laboratories and Healthcare's Marketable Securities for the quarter that ended in Mar. 2025 was ₹0.0 Mil.

Nidan Laboratories and Healthcare  (NSE:NIDAN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Nidan Laboratories and Healthcare Marketable Securities Related Terms

Nidan Laboratories and Healthcare Marketable Securities Historical Data

* Premium members only.

The historical data trend for Nidan Laboratories and Healthcare's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nidan Laboratories and Healthcare Marketable Securities Chart

Nidan Laboratories and Healthcare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Nidan Laboratories and Healthcare Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:NIDAN
67GF Score
Nidan Laboratories and Healthcare Ltd NSE:NIDAN
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nidan Laboratories and Healthcare Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0.0 Mil mean?
Nidan Laboratories and Healthcare (NSE:NIDAN) has a Marketable Securities of ₹0.0 Mil as of Mar. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Nidan Laboratories and Healthcare and its competitors.
Is Nidan Laboratories and Healthcare's Marketable Securities too high?
Nidan Laboratories and Healthcare's current Marketable Securities is ₹0.0 Mil. Overall, Nidan Laboratories and Healthcare has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Nidan Laboratories and Healthcare's Marketable Securities compare to TMO and DHR?
Nidan Laboratories and Healthcare's Marketable Securities of ₹0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Diagnostics & Research company?
A good Marketable Securities depends on the Medical Diagnostics & Research industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Nidan Laboratories and Healthcare and its competitors. Nidan Laboratories and Healthcare's current Marketable Securities is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nidan Laboratories and Healthcare stock overvalued right now?
Nidan Laboratories and Healthcare (NSE:NIDAN) has a current Marketable Securities of ₹0.0 Mil. The current Marketable Securities is ₹0.0 Mil. Nidan Laboratories and Healthcare's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Nidan Laboratories and Healthcare (NSE:NIDAN), the current Marketable Securities is ₹0.0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nidan Laboratories and Healthcare Business Description

Address Vartak Road, SY No. 294/A H. No. 18, Swapnshilpa Bunglow, Behind Aarti Apartment, Virar West, Palghar, Virar, MH, IND, 401303
Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.
67GF Score

Get the complete analysis for NSE:NIDAN

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.50
Price